Biomerics, a leader and innovator of medical polymer solutions, has announced the launch of its Quadrathane family of biomaterials, a complete line of polycarbonate-based thermoplastic polyurethane (TPUs) materials for the medical device market. The Quadrathane™ family of polycarbonate-based thermoplastic polyurethanes is available in aliphatic and aromatic formulations. Quadrathane™ offers superior biocompatibility, mechanical properties, chemical resistance and oxidative stability when compared to other TPUs. Quadrathane™ biomaterials are specifically designed for long-term implantable applications where biocompatibility and biostability are critical to a device’s performance. These grades have passed ISO 10993 and USP Class VI biological testing, including hemocompatibility, cytotoxicity, irritation and sensitization testing.
The Quadrathane™ ALC (aliphatic polycarbonate) grades are non-yellowing and offer unique body softening properties. They are typically used in catheter applications, where softening and biodurability are required, such as hemodialysis, drainage, vascular access and pacemaker leads. The ALC family of polymers is available in eight standard body softening grades and eight standard high-resiliency grades, ranging in durometers from 75A-72D. The Quadrathane™ ARC (aromatic polycarbonate) grades deliver superior chemical resistance and toughness to long-term devices. These polymers are useful in applications where solvent resistance, resiliency and biodurability are required, such as vascular access and orthopedic devices. All grades are naturally clear, and are designed for use in extrusion, injection molding and solution processes. Standard grades may be customized with radiopacifiers, colors, antimicrobials or other additives for a given application. “Biomerics specializes in the rapid development of proprietary biopolymers to solve our customers’ application requirements,” says Travis Sessions, President and CEO of Biomerics. “Our Quadrathane™ line of materials was specifically developed to solve unmet performance, supply and quality issues experienced by many of our customers. This product line expands the tool box of materials available to device engineers to build new-to-market devices and improve patient outcomes.” Biomerics manufactures their products in ISO 9001 and ISO 13485 registered facilities.
Previous News
Next News
-
Paraxylene from 100% renewable plant sugars for 100% natural, renewable, plant-based PET
-
Oil drops as concerns over European and US economies feed demand worries
-
BASF to increase compounding capacity for polyamide and PBT at Schwarzheide
-
Petrochemicals industry in Japan staggers under earthquake and tsunami
-
Live and Webcast Auction for Solo Cup Co. to include single-use food service products manufacturing equipment
-
Exports, output, production capacity to continue to expand in 2011 for Saudi petrochemical industry
-
Amid weak demand and ample supplies, ADNOC sells 150,000 tons of July spot naphtha at lower premiums
-
Naphtha crack spread in Asia falls
-
Sasol Ltd. acquires 50% stake in Talisman Energy’s shale natural gas assets
-
PE offers from Asia could make Brazil rethink prices for July
-
Indorama Inaugurates a New Recycling Line in San Roque
-
Indorama Ventures, Varun Beverages Form Joint Venture For 100,000 Tons of PET Recycling
-
World's First Plant-Based Plastic Christmas Trees
-
Enhancing Mechanical Recycling Quality Through Research in Plastic Sorting, Decontamination, Compounding and Analysis
-
AIMPLAS Develops a Project To Reduce Odors In Cars With Contaminant- Free Recycled Material
-
LyondellBasell Unveils New Polypropylene Impact Copolymer: Pro-Fax EP648R
-
BASF Inaugurates New NPG Plant at Zhanjiang Verbund Site and Launches NEOL® NPG with Reduced Product Carbon Footprint
-
India’s Plastics Industry Gears Up for a 4X Export Leap
-
Avient Collaborates with ReForm Composites Engineering to Accelerate Adoption of Thermoplastic Composite Solutions in Construction
-
Syensqo Pioneers Recycling Technology For Sulfone Polymers
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}